Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 163

1.

Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.

Rolfes MA, Gross FL, Flannery B, Meyers AFA, Luo M, Bastien N, Fowler RA, Katz JM, Levine MZ, Kumar A, Uyeki TM; Canadian Severe Influenza Study (CSIS) and the Randomized, Double-Blinded Controlled Trial Comparing High vs Standard Dose Oseltamivir in Severe, Influenza Infection in ICU (ROSII) Study Groups.

J Infect Dis. 2018 Jan 12. doi: 10.1093/infdis/jiy013. [Epub ahead of print]

PMID:
29342251
2.

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.

Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B.

Vaccine. 2018 Jan 25;36(4):467-472. doi: 10.1016/j.vaccine.2017.12.014. Epub 2017 Dec 14.

PMID:
29249545
3.

An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.

Florek NW, Campos LM, Braun KM, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC.

Vaccine. 2018 Jan 29;36(5):758-764. doi: 10.1016/j.vaccine.2017.12.024. Epub 2017 Dec 15.

PMID:
29249543
4.

Update: Influenza Activity - United States, October 1-November 25, 2017.

Dugan VG, Blanton L, Elal AIA, Alabi N, Barnes J, Brammer L, Burns E, Cummings CN, Davis T, Flannery B, Fry AM, Garg S, Garten R, Gubareva L, Jang Y, Kniss K, Kramer N, Lindstrom S, Mustaquim D, O'Halloran A, Olsen SJ, Sessions W, Taylor C, Trock S, Xu X, Wentworth DE, Katz J, Jernigan D.

MMWR Morb Mortal Wkly Rep. 2017 Dec 8;66(48):1318-1326. doi: 10.15585/mmwr.mm6648a2.

5.

Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016.

Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson M, Monto AS, Martin ET, Belongia EA, McLean H, Fry AM, Havers F.

Clin Infect Dis. 2017 Oct 23. doi: 10.1093/cid/cix922. [Epub ahead of print]

PMID:
29069334
6.

Respiratory syncytial virus hospitalization in middle-aged and older adults.

Malosh RE, Martin ET, Callear AP, Petrie JG, Lauring AS, Lamerato L, Fry AM, Ferdinands J, Flannery B, Monto AS.

J Clin Virol. 2017 Nov;96:37-43. doi: 10.1016/j.jcv.2017.09.001. Epub 2017 Sep 7.

PMID:
28942341
7.

Letter in response to commentary by Small and Cronin.

Grohskopf L, Foppa I, Flannery B, Fry A.

Vaccine. 2017 Sep 18;35(39):5225. doi: 10.1016/j.vaccine.2017.07.112. No abstract available.

PMID:
28867044
8.

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.

Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B.

N Engl J Med. 2017 Aug 10;377(6):534-543. doi: 10.1056/NEJMoa1700153.

PMID:
28792867
9.

Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.

Blanton L, Alabi N, Mustaquim D, Taylor C, Kniss K, Kramer N, Budd A, Garg S, Cummings CN, Chung J, Flannery B, Fry AM, Sessions W, Garten R, Xu X, Elal AIA, Gubareva L, Barnes J, Dugan V, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2017 Jun 30;66(25):668-676. doi: 10.15585/mmwr.mm6625a3.

10.

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States.

Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Petrie JG, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Fry AM.

J Infect Dis. 2017 Jul 15;216(2):284-285. doi: 10.1093/infdis/jix286. No abstract available.

PMID:
28633308
11.

Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014.

Flannery B, Reynolds SB, Blanton L, Santibanez TA, O'Halloran A, Lu PJ, Chen J, Foppa IM, Gargiullo P, Bresee J, Singleton JA, Fry AM.

Pediatrics. 2017 May;139(5). pii: e20164244. doi: 10.1542/peds.2016-4244. Epub 2017 Apr 3.

PMID:
28557757
12.

Are children's vitamin D levels and BMI associated with antibody titers produced in response to 2014-2015 influenza vaccine?

Lin CJ, Martin JM, Cole KS, Zimmerman RK, Susick M, Moehling KK, Levine MZ, Spencer S, Flannery B, Nowalk MP.

Hum Vaccin Immunother. 2017 Jul 3;13(7):1661-1665. doi: 10.1080/21645515.2017.1299837. Epub 2017 Mar 31.

PMID:
28362550
13.

RE: "INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN".

Ferdinands JM, Foppa IM, Fry AM, Flannery BL, Belongia EA, Jackson ML.

Am J Epidemiol. 2017 Apr 1;185(7):613. doi: 10.1093/aje/kww227. No abstract available.

PMID:
28338844
14.

Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.

Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, Berman L, Spencer S, Fry AM.

MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):167-171. doi: 10.15585/mmwr.mm6606a3.

15.

Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.

Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, Belongia EA.

Clin Infect Dis. 2017 Mar 1;64(5):544-550. doi: 10.1093/cid/ciw816. Epub 2016 Dec 29.

PMID:
28039340
16.

Update: Influenza Activity - United States, October 2-December 17, 2016.

Shang M, Blanton L, Kniss K, Mustaquim D, Alabi N, Barnes S, Budd A, Davlin SL, Kramer N, Garg S, Cummings CN, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, Bresee J, Sessions W, Garten R, Xu X, Elal AI, Gubareva L, Barnes J, Wentworth DE, Burns E, Katz J, Jernigan D, Brammer L.

MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(5051):1439-1444. doi: 10.15585/mmwr.mm655051a5.

17.

Letter to the editor: Regarding the editorial by Penttinen and Friede.

Fry AM, Flannery B, Olsen SJ, Grohskopf L, Bresee J.

Euro Surveill. 2016 Oct 6;21(40). doi: 10.2807/1560-7917.ES.2016.21.40.30366. No abstract available.

18.

Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication.

Flannery BM, Bruun DA, Rowland DJ, Banks CN, Austin AT, Kukis DL, Li Y, Ford BD, Tancredi DJ, Silverman JL, Cherry SR, Lein PJ.

J Neuroinflammation. 2016 Oct 12;13(1):267.

19.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B; US Flu VE Investigators; U.S. Flu VE Investigators.

Clin Infect Dis. 2016 Dec 15;63(12):1564-1573. Epub 2016 Oct 4.

20.

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients.

Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR.

BMC Infect Dis. 2016 Sep 22;16(1):503.

Supplemental Content

Loading ...
Support Center